CAS 498577-53-0: [1,1'-Biphenyl]-2-carboxamide,2'-[[[(4-methoxyphenyl)acetyl]amino]methyl]-N-[2-(3-pyridinyl)ethyl]-

AVE-0118 is a potassium channel blocker and suppresses persistent atrial fibrillation.

2'-((2-(4-Methoxyphenyl)acetamido)methyl)-N-(2-(pyridin-3-yl)ethyl)-[1,1'-biphenyl]-2-carboxamide is a synthetic compound characterized by its biphenyl carboxamide structure. It is derived through organic synthesis involving the strategic assembly of methoxyphenyl, pyridine, and carboxamide moieties. The mode of action of this compound can be attributed to its potential interactions within biological systems, where it may function to modulate activity at specific molecular targets. The presence of both aromatic and heterocyclic components suggests its ability to engage in various non-covalent interactions, such as hydrogen bonding and π-π stacking, which are crucial for its bioactivity. This compound's uses and applications span across pharmacological research, where its structure allows investigation into receptor binding properties and potential therapeutic effects. It may serve as a lead compound in the development of new drugs targeting specific pathways or diseases. Further research might explore its efficacy and selectivity in biological assays, contributing valuable insights into drug discovery and development.

AVE-0118